A citation-based method for searching scientific literature

Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett, Gillian E Caughey. BMC Geriatr 2017
Times Cited: 773







List of co-cited articles
285 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.
Denis O'Mahony, David O'Sullivan, Stephen Byrne, Marie Noelle O'Connor, Cristin Ryan, Paul Gallagher. Age Ageing 2015
12

Frailty in older adults: evidence for a phenotype.
L P Fried, C M Tangen, J Walston, A B Newman, C Hirsch, J Gottdiener, T Seeman, R Tracy, W J Kop, G Burke,[...]. J Gerontol A Biol Sci Med Sci 2001
11


Clinical consequences of polypharmacy in elderly.
Robert L Maher, Joseph Hanlon, Emily R Hajjar. Expert Opin Drug Saf 2014
770
9

Reducing inappropriate polypharmacy: the process of deprescribing.
Ian A Scott, Sarah N Hilmer, Emily Reeve, Kathleen Potter, David Le Couteur, Deborah Rigby, Danijela Gnjidic, Christopher B Del Mar, Elizabeth E Roughead, Amy Page,[...]. JAMA Intern Med 2015
642
9

Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.
Terri R Fried, John O'Leary, Virginia Towle, Mary K Goldstein, Mark Trentalange, Deanna K Martin. J Am Geriatr Soc 2014
321
8

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.
Karen Barnett, Stewart W Mercer, Michael Norbury, Graham Watt, Sally Wyke, Bruce Guthrie. Lancet 2012
8

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.
Danijela Gnjidic, Sarah N Hilmer, Fiona M Blyth, Vasi Naganathan, Louise Waite, Markus J Seibel, Andrew J McLachlan, Robert G Cumming, David J Handelsman, David G Le Couteur. J Clin Epidemiol 2012
621
7

FUNCTIONAL EVALUATION: THE BARTHEL INDEX.
F I MAHONEY, D W BARTHEL. Md State Med J 1965
7

An update on the clinical consequences of polypharmacy in older adults: a narrative review.
Jonas W Wastesson, Lucas Morin, Edwin C K Tan, Kristina Johnell. Expert Opin Drug Saf 2018
133
6

Association between polypharmacy and death: A systematic review and meta-analysis.
Nattawut Leelakanok, Andrea L Holcombe, Brian C Lund, Xiaomei Gu, Marin L Schweizer. J Am Pharm Assoc (2003) 2017
104
6

Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many.
Cathal A Cadogan, Cristín Ryan, Carmel M Hughes. Drug Saf 2016
108
5

Interventions to improve the appropriate use of polypharmacy for older people.
Audrey Rankin, Cathal A Cadogan, Susan M Patterson, Ngaire Kerse, Chris R Cardwell, Marie C Bradley, Cristin Ryan, Carmel Hughes. Cochrane Database Syst Rev 2018
158
5

A global clinical measure of fitness and frailty in elderly people.
Kenneth Rockwood, Xiaowei Song, Chris MacKnight, Howard Bergman, David B Hogan, Ian McDowell, Arnold Mitnitski. CMAJ 2005
5

Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.
Elizabeth D Kantor, Colin D Rehm, Jennifer S Haas, Andrew T Chan, Edward L Giovannucci. JAMA 2015
644
5

An overview of prevalence, determinants and health outcomes of polypharmacy.
Mina Khezrian, Chris J McNeil, Alison D Murray, Phyo K Myint. Ther Adv Drug Saf 2020
50
10

Polypharmacy and Medication Management in Older Adults.
Jennifer Kim, Abby Luck Parish. Nurs Clin North Am 2017
49
10

Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.
Donna M Fick, James W Cooper, William E Wade, Jennifer L Waller, J Ross Maclean, Mark H Beers. Arch Intern Med 2003
4

Patient Characteristics Associated with Polypharmacy and Inappropriate Prescribing of Medications among Older Adults with Cancer.
Gopi K Prithviraj, Siran Koroukian, Seunghee Margevicius, Nathan A Berger, Rakesh Bagai, Cynthia Owusu. J Geriatr Oncol 2012
92
4

Polypharmacy in patients with advanced cancer and the role of medication discontinuation.
Thomas W LeBlanc, Michael J McNeil, Arif H Kamal, David C Currow, Amy P Abernethy. Lancet Oncol 2015
85
4

A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.
Andrew M Whitman, Kathlene A DeGregory, Amy L Morris, Erika E Ramsdale. Oncologist 2016
33
12

Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study.
Mark James Rawle, Rachel Cooper, Diana Kuh, Marcus Richards. J Am Geriatr Soc 2018
52
7


International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.
Hans Wildiers, Pieter Heeren, Martine Puts, Eva Topinkova, Maryska L G Janssen-Heijnen, Martine Extermann, Claire Falandry, Andrew Artz, Etienne Brain, Giuseppe Colloca,[...]. J Clin Oncol 2014
867
4

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010.
Bruce Guthrie, Boikanyo Makubate, Virginia Hernandez-Santiago, Tobias Dreischulte. BMC Med 2015
354
4

Defining polypharmacy in the elderly: a systematic review protocol.
Seyede Salehe Mortazavi, Mohsen Shati, Abasali Keshtkar, Seyed Kazem Malakouti, Mohsen Bazargan, Shervin Assari. BMJ Open 2016
68
5


The anticholinergic risk scale and anticholinergic adverse effects in older persons.
James L Rudolph, Marci J Salow, Michael C Angelini, Regina E McGlinchey. Arch Intern Med 2008
458
4

Polypharmacy in nursing home in Europe: results from the SHELTER study.
Graziano Onder, Rosa Liperoti, Daniela Fialova, Eva Topinkova, Matteo Tosato, Paola Danese, Pietro Folino Gallo, Iain Carpenter, Harriet Finne-Soveri, Jacob Gindin,[...]. J Gerontol A Biol Sci Med Sci 2012
190
4

Potentially inappropriate medication use among elderly home care patients in Europe.
Daniela Fialová, Eva Topinková, Giovanni Gambassi, Harriet Finne-Soveri, Pálmi V Jónsson, Iain Carpenter, Marianne Schroll, Graziano Onder, Liv Wergeland Sørbye, Cordula Wagner,[...]. JAMA 2005
407
3

Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals.
Paul Gallagher, Pierre Olivier Lang, Antonio Cherubini, Eva Topinková, Alfonso Cruz-Jentoft, Beatriz Montero Errasquín, Pavla Mádlová, Beatrice Gasperini, Hilde Baeyens, Jean-Pierre Baeyens,[...]. Eur J Clin Pharmacol 2011
210
3


Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.
Eline Tommelein, Els Mehuys, Mirko Petrovic, Annemie Somers, Pieter Colin, Koen Boussery. Eur J Clin Pharmacol 2015
152
3

Development and validation of the medication regimen complexity index.
Johnson George, Yee-Teng Phun, Michael J Bailey, David C M Kong, Kay Stewart. Ann Pharmacother 2004
279
3

Appropriate prescribing in elderly people: how well can it be measured and optimised?
Anne Spinewine, Kenneth E Schmader, Nick Barber, Carmel Hughes, Kate L Lapane, Christian Swine, Joseph T Hanlon. Lancet 2007
631
3

Prevalence and factors associated with polypharmacy in older people with cancer.
Justin P Turner, Sepehr Shakib, Nimit Singhal, Jonathon Hogan-Doran, Robert Prowse, Sally Johns, J Simon Bell. Support Care Cancer 2014
79
3

Potentially inappropriate medication use in older patients with breast and colorectal cancer.
Meghan S Karuturi, Holly M Holmes, Xiudong Lei, Michael Johnson, Carlos H Barcenas, Scott B Cantor, Gary E Gallick, Robert C Bast, Sharon H Giordano. Cancer 2018
27
11

Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness.
Yael Schenker, Seo Young Park, Kwonho Jeong, Jennifer Pruskowski, Dio Kavalieratos, Judith Resick, Amy Abernethy, Jean S Kutner. J Gen Intern Med 2019
26
11

Polypharmacy and the management of the older cancer patient.
L Balducci, D Goetz-Parten, M A Steinman. Ann Oncol 2013
60
5

Polypharmacy and potentially inappropriate medication use in geriatric oncology.
Manvi Sharma, Kah Poh Loh, Ginah Nightingale, Supriya G Mohile, Holly M Holmes. J Geriatr Oncol 2016
89
3


Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment.
Kyung Suk Choi, Young Mi Jeong, Eunsook Lee, Kwang Ill Kim, Jeong Yee, Byung Koo Lee, Jee Eun Chung, Sandy Jeong Rhie, Hye Sun Gwak. Aging Clin Exp Res 2018
14
21


Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis.
Mostafa R Mohamed, Erika Ramsdale, Kah Poh Loh, Asad Arastu, Huiwen Xu, Spencer Obrecht, Daniel Castillo, Manvi Sharma, Holly M Holmes, Ginah Nightingale,[...]. Oncologist 2020
43
6


Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study.
David T Eton, Djenane Ramalho de Oliveira, Jason S Egginton, Jennifer L Ridgeway, Laura Odell, Carl R May, Victor M Montori. Patient Relat Outcome Meas 2012
159
3

Association of Polypharmacy With 1-Year Trajectories of Cognitive and Physical Function in Nursing Home Residents: Results From a Multicenter European Study.
Davide Liborio Vetrano, Emanuele Rocco Villani, Giulia Grande, Silvia Giovannini, Maria Camilla Cipriani, Ester Manes-Gravina, Roberto Bernabei, Graziano Onder. J Am Med Dir Assoc 2018
31
9

Polypharmacy among older Australians, 2006-2017: a population-based study.
Amy T Page, Michael O Falster, Melisa Litchfield, Sallie-Anne Pearson, Christopher Etherton-Beer. Med J Aust 2019
53
5

Cognitive decline and polypharmacy in an elderly population.
Ximena A Oyarzun-Gonzalez, Kira C Taylor, Steven R Myers, Susan B Muldoon, Richard N Baumgartner. J Am Geriatr Soc 2015
20
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.